Social Media

Leslie Schrader's picture

Forget an Apple a Day, Today Consumers Want an App a Day

1 comment

Yes, that’s right. We are in the midst of a [[wysiwyg_imageupload:133:]]
paradigm shift and consumers are now looking to technology for information and personal health and wellness and then looking to physicians and healthcare providers for “second opinions” to validate their personal conclusions.

As the wellbeing movement expands and changes, it presents marketers with more opportunities, and challenges, to reach consumers with health and wellness messages. From what to eat and what to wear, to what to do and what one should do, leading a healthy lifestyle means different things to different populations. And, there are more and more sources and channels where consumers can access information to help them achieve the level of health and wellness they want in their lives. Marketers can be the ultimate resource and work with the latest technology and tools to curate content and intersect with consumers where they are. Read full post »

Sultana Ali's picture

Saving Lives Via Social Media


Editor's Note: This post originally ran on the Ketchum Blog and can be found here. 


Times They Are a-Changin’! These immortal words written [[wysiwyg_imageupload:121:]]
and performed by Bob Dylan in 1964 continue to echo through our world today. Perhaps it is nowhere more present than in the world of social media in the manner of altering the way we share our personal choices, particularly when it comes to topics of health.

It is unlikely in 1968 when The Uniform Anatomical Gift Act (UAGA) provided the legal standing for organ transplantation, that people might have imagined there would someday be a national computer registry of donated organs, but that is exactly what happened in 1984 through the National Organ Transplant Act (NOTA). Eventually, states began to offer an individual the option to list “organ donor” as a status on their driver’s license; a private and personal choice declaring that if something were to happen to that person, their organs could be transplanted if determined usable. Read full post »

Andrew Lamb's picture

A European Perspective on Social Media and the FDA’s New Guidance

1 comment

While it falls short of the comprehensive guidance [[wysiwyg_imageupload:115:]]
on social media that many were hoping for, the FDA’s new document on responding to unsolicited requests does have an interest and relevance for those working in healthcare communications on the other side of the Atlantic.

Of course, no digital project is completely ‘local’ and Europeans should always have half an eye on developments elsewhere in the world. More importantly though, the FDA has given us a useful clue to what regulators are thinking and the issues they face in coming up with clear rules for the rapidly evolving environment of the web and social media. It could also set the tone for European guidance, if and when it appears.

The most significant aspect of the FDA’s new document is that: Read full post »

In: Digital & Social Media  /   filed under: EU | FDA | pharma | Social Media | UK
Suzannah Palinkas's picture

We Must First Ask the Question - What Do We Want to Accomplish?


It seems simple enough and a logical first step to [[wysiwyg_imageupload:114:]]
planning anything but so many times, across multiple disciplines, we hear:

“We need a Facebook page.”

“We need to have a blog.”

“We need to be Tweeting.”

But why? At a recent social media conference, specifically in the Pharma space, the question and principle came up multiple times… we need to start by asking a few simple questions. What are we trying to accomplish? Reaching who? What then are we going to do with the information? Why do we need to be in the social media space?

One can’t deny that online vehicles are growing rapidly, exponentially expanding, and that social media channels are just too large a communication vehicle to ignore. Even so, there has to be the right fit between what a company wants to accomplish online and the vehicles through which it achieves those goals. And it seems that sometimes those key questions haven’t been answered, and the result is an inappropriate or useless execution that simply checks a box. Read full post »

Andrea Fuller's picture

FDA’s New Social Media Guidelines – How Do I Handle Unsolicited Inquires for Off-Label Uses?


The days of looking up contact information in the[[wysiwyg_imageupload:113:]]
yellow pages has become obsolete. These days we take to the Internet to find out information about whom to contact, and expect to find it quickly and easily. If you were a new visitor to your company’s site would you be able to find the best person to answer your question quickly and easily? If you’re not sure, go take a look.

The Basics of Handling Unsolicited  Inquiries – Off-Label

The FDA understands customers will contact your company requesting information about off-label uses for prescription drugs or medical devices. The question is not if you should handle it but rather, how you should handle it. The answer is good customer service.

Research and online behavioral analysis (Nielsen Norman Group) show time and time again the majority of people prefer the ability to contact a real live individual over a generic contact form or email address. Read full post »

In: Digital & Social Media  /   filed under: FDA | pharma | Social Media